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Oral Mesotherapy: Might Be 
Considered as An Adjunctive 
Technique for the Different 
Surgical Procedures?
Nermin Yussif
Abstract
The bidirectional relationship between local and systemic pathways makes 
it difficult to provide a safe intraoral treatment. Nowadays, mesotherapy has 
become more necessary in dentistry to overcome the huge number of surgical 
interventions either for therapeutic or for cosmetic purposes. It also limits the 
need for systemic drugs achieving favorable outcomes with minimal side effects. 
Further researches are needed to examine the usage of mesotherapy in different 
oral problems. In dermal mesotherapy, dermatologists used several materi-
als as hyaluronic acid, collagen, hydroxyapatite, carboxymethyl cellulose, and 
silicone. Such materials exhibit different manners according to their resorption 
rate: temporary, semipermanent, permanent, and combinations. Furthermore, 
B-tricalcium phosphate and hydroxyapatite are considered as tissue stimulators by 
stimulation of collagen formation. Combinations of temporary materials in order 
to achieve immediate filling effect with tissue stimulator as HA or B-TCP achieve 
better results.
Keywords: oral mesotherapy, intraepidermic injection, minimally invasive 
techniques, vitamins, tooth traction, depigmentation, connective tissue thickening
1.  An overview on the original mesotherapy technique for 
dermatological uses
The aim behind mesotherapy was to create a new technique, which favors the 
supplementation of needed agents directly and locally to the site of complaint. As 
previously mentioned, the proposed theory by Pistor depends mainly on the direct 
effect of the used drug on the tissue originating from the mesoderm [1, 2]. The 
mesoderm is one of the primary germ layers of the embryo that is responsible for 
the development of skin, connective tissue, muscles, tendons, and circulatory sys-
tem. It is mainly responsible for skin vitality and health [3]. The injection technique 
of mesotherapy depends mainly on the anatomical, histological and geometrical 
landmarks of the target tissues. Mesointerface is the horizontal interface between 
the injected agents and the injected region. For maximum benefits, the injected 
surface is inversely proportional to the amount and molecular weight of the injected 
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agent. The wider the mesointerface is, the greater the number of the dermal recep-
tors that are activated [4].
On the other hand, the vertical component depends on the depth of penetration. 
Mesotherapy could be injected in the epidermis, dermis, or subcutaneous [1]. The 
more superficial injection is, the longer the drug remains in the tissue. It permits 
sustained release of the drug with slow and progressive diffusion into the surround-
ing tissues [2, 5, 6].
The technique depends on the skin characteristics and components. It deter-
mines the type of drug injected, the technique of injection, and the drug dosage. 
The skin has a natural sustained releasing property. Therefore, the nature of the 
skin determines the layers that are suitable for injection. The injection process must 
be in the superficial layers (intradermal) for the drug to remain as long as possible 
and for its clearance to become slower. If the drug is injected deeper, its clearance 
becomes faster. So the more superficial the injection is, the longer the drug remains 
in place (being far more powerful and efficient) [6].
2. FDA and mesotherapy
The FDA is the association concerning about the assurance of the food and drug 
safety. Although FDA did not approve the mesotherapy technique, it approved 
many drugs that have been used in mesotherapy as aminophylline, yohimbine, 
procaine, lidocaine, and marcaine [7]. Other drugs do not have the FDA approval 
for any purpose of usage as it is beyond the scope of FDA because they do not 
consider drugs as vitamins and minerals [8]. It also approved the delivery method 
using mesogun [1].
All the drugs used in mesotherapy are considered by the FDA as off-label used 
drugs. The off-label approval includes the approved drug and the approved route of 
administration of this drug. The local anesthetic agents calcitonin, hyaluronidase, 
and collagenase are not approved by the FDA [9].
3. Benefits and uses of mesotherapy
The local treatment in mesotherapy has superior advantages over the sys-
temic one either oral or parental. Firstly, it avoids the side effects resulted from 
drug metabolism and excretion in the stomach, intestine, liver, and kidneys. 
Secondly, the effectiveness of the local drug is directly administrated into the 
area of interest. Finally, it minimizes the dosage used into 1% of the dosage used 
systemically [1].
Improvement of blood flow, removal of fibrotic tissue, an increase in the con-
nective tissue quality and amount, hair loss (mesohair), skin rejuvenation (meso-
glow), excessive fat and cellulite removal, improvement of the lymphatic drainage, 
osteoarthritis, and pain relief are the main medical indications of mesotherapy [10]. 
On the financial point of view, it is a cost-effective modality that provides success-
ful drug delivery using inexpensive equipment with short-term practice needed for 
the general practitioner [11].
Oral mesotherapy is an old technique which was commonly applied in order to 
introduce various agents. Infiltration, intraligamentary, intramucosal, intralesional, 
and intraepidermic injection are common names for oral mesotherapy technique 
that have been used previously. The different names were more related to different 
layers and structures of the oral cavity.
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4. Common agents delivered by oral mesotherapy
4.1 Local anesthesia
Local anesthesia is a reversible blockage of nerve conduction in a defined area 
that resulted in loss of sensation [12]. It can be performed using various techniques 
which differ according to the width of the area needed to be anesthetized as well as 
tissue depth and its relation to target nerve.
Local infiltration is one of the techniques in which the local anesthetic solution 
is administrated submucosal, intradermal, or intraligamentary in order to anesthe-
tize the nerve endings that innervate the target region. The submucosal injection 
involves the drug administration in the deep dermis layer reaching the lipid layer 
with 45 angulation and thicker needle, while the intradermal injection involves 
introduction of anesthetic agent into the superficial dermis (papillary dermis) 
with 10 to 15 degrees using fine needle [13, 14]. Intraligamentary (or periodontal) 
anesthesia is a type of the locally delivered anesthetic technique in which the needle 
is introduced in the mesiobuccal and distobuccal directions delivering the anes-
thetic agent in an apical direction. Its accuracy, easiness, minimal administration of 
anesthetic solution, efficiency, and the lack of harmful effects to the adjacent peri-
odontal apparatus are the main advantages of this technique [15, 16]. The pressure 
needed for such technique is necessary, and it remains the main cause behind the 
development of local inflammation and pain which may last up to 7 days as well as 
bone and root resorption in relation to the injection site [17]. Defective enamel dis-
orders were also detected following intraligamentary injection of local anesthesia. 
In hemophilic patients, intraligamentary injections are usually not recommended to 
avoid hematoma formation. It was also avoided in deciduous teeth [18] (Figure 1).
On the other hand, the field block technique involves the introduction of the 
anesthetic agent in a circular configuration around the operative site [19].
The interseptal technique is a simple technique which provides adequate control 
of pain and bleeding especially during emergency conditions. During infection and 
inflammatory conditions, interseptal technique is usually preferred. A 27 gauge 
needle is inserted at 45° at the center of the interdental papilla. Minimal amount 
(0.2–0.4 ml) of the anesthetic agent is injected. It was found that interseptal tech-
nique showed higher anesthetic efficiency than the intraligamentary and intraosse-
ous injection [18, 19].
The intrapulpal technique is one of the most common techniques that are used 
during endodontic treatment especially in acute phases of pulpal inflammation. 
Figure 1. 
Intraligamentary injection [18].
Periodontal Disease - Diagnostic and Adjunctive Non-surgical Considerations
4
Despite its rapid onset, effectiveness, and safeness, its action has shorter dura-
tion than other techniques [18]. Finally, the intraosseous technique provides rapid 
introduction, which is commonly used following failure of the field or nerve block 
technique. It depends on the direct introduction of the anesthetic agent to the 
interdental bone resulting in rapid delivery of the anesthetic agent to the blood 
circulation which should be avoided in cardiovascular patients [19] (Figure 2).
4.2 Corticosteroids
Corticosteroids are widely used for the management of numerous oral inflam-
matory conditions due to their anti-inflammatory and immune modulatory effects. 
They could be delivered either intramucosally (within the lesion), topically, or 
systemically [20].
Intralesional (intradermal) corticosteroid injection is a favorite method in 
delivering the drug directly to the target site resulting in rapid action as well as less 
systemic complications. Injectable steroids are clear fluids; their color and dose 
depend on the formulation of steroids used. It is commonly used in managing the 
longstanding oral lichen planus lesions and oral submucous fibrosis, but it has a 
localized side effect such as mucosal atrophy [21, 22]. Hydrocortisone and triam-
cinolone are the commonest formulas used in local delivery with weekly injections 
reaching up to 11 injections [22, 23].
Although surgical excision is considered the gold standard technique for treat-
ing mucocele and orofacial granulomatosis, the use of intralesional corticosteroid 
injection was also reported. However, some investigators have suggested that the 
intralesional corticosteroid could be used as a new modality in the treatment, but 
cases of relapse with corticosteroid have been reported [24, 25]. Great differences 
were detected in the used doses and the number of sessions according to the sever-
ity, extension, and the systemic condition of the patient [22, 23, 26–28].
4.3 Vitamins
According to literature, vitamins were usually introduced either by intraliga-
mentary or intraepidermic techniques. The intraepidermic technique was con-
ducted in 2016 by Yussif et al. [29].
4.3.1 Vitamin D
Although vitamin D has a great role in maintaining the bone health and metabo-
lism, it is just recently discovered that vitamin D deficiency has a great role in the 
occurrence and progression of various periodontal diseases. It is a steroid hormone 
that controls the bone metabolism and calcium homeostasis [30–32].
Figure 2. 
Corticosteroids and chronic gingival inflammation.
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It was detected that the level of vitamin D reaches its lowest levels during 
periodontal disease especially aggressive periodontitis. The daily supplementation is 
important to maintain the periodontal health [30–33].
The introduction of locally delivered vitamin D injections provides short treat-
ment visits, non-traumatic, less patient morbidity, non-stressful procedure with no 
post-operative side effects. The procedure is not painful. There is also no need for 
preoperative local anesthesia. It could be either delivered alone [34] or in combina-
tion with calcium [35]. The promising improvement of the regenerative power 
was attributed to minimal trauma and preserving the periosteum adapted over the 
alveolar bone. Great reduction of the clinical attachment loss and the absence of 
bleeding on probing were also detected indicating the absence of inflammation. On 
the radiographic examination, improvement of the alveolar bone density as well as 
accentuation of lamina dura was also reported [34, 35].
In orthodontic therapy, locally delivered vitamin D is commonly introduced in 
small doses using periodontal injection technique in order to accelerate the osteo-
clastic activity in the pressure site which in role accelerates the orthodontic move-
ment. The dose and the number of the treatment sessions are determined according 
to the distance that the tooth needed to travel [34, 36] (Figure 3).
4.3.2 Vitamin C
Ascorbic acid is also an essential vitamin in the treatment of periodontal dis-
eases. Its deficiency causes impaired wound healing with higher bleeding index. 
Lower levels of serum vitamin C were reported in periodontitis. The importance of 
vitamin C lies behind its powerful scavenging and antioxidant effect as it usually 
Figure 3. 
Vitamin D injection and periodontitis [37].
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accumulates in the immune cells as PMNs and macrophages and significantly 
enhances chemotaxis, phagocytic, opsonization, degranulation, and killing func-
tions of immune cells [33, 38]. It also has a great role in collagen biosynthesis [39]. It 
could be supplied orally, topically, or by intraepidermal injection [37, 40]. Vitamin 
C is widely used in dermal mesotherapy as it restores the tissue integrity and bright-
ness by neutralizing the free radicals in the newly formed tissues, stimulates the 
collagen formation, and inhibits melanogenesis [10, 41].
Growing evidence has suggested the role of vitamin C in enhancing the quality 
and outcome of the orthodontic treatment. This is proven when tooth movement 
was enhanced following systemic administration of vitamin C for 17 days [42, 43]. 
It was also noticed that its deficiency is accompanied with limited tooth movement 
and arrested osteogenesis [44].
Vitamin C induces its action through modifying the osteoclastic activity, 
osteogenesis, tissue healing, and periodontal ligament organization. It increases 
the collagen I synthesis that represents the main component of bone matrix and 
periodontal ligament [45]. It also accelerates the bone mineralization, calcium 
absorption, formation of collagen type X, expression of alkaline phosphatase, and 
osteoblast growth and differentiation [46, 47] (Figure 4).
Furthermore, the depigmenting effect of vitamin C depends mainly on its 
antioxidant property. The efficiency of vitamin C in the treatment of physiologic 
or pathologic dermal problems such as hyperpigmentation, aging, and dryness was 
promising due to several factors that are not only related to its direct interaction 
with melanin and melanocytes but also due to the overall effect on the applied 
tissues. Once vitamin C is introduced to the target tissue, it binds efficiently to 
melanin because melanin is the main store of ROS, calcium, and copper content 
that causes intracellular deficiency of these items. Lower intracellular calcium level 
causes failure of melanocytes to perform cellular adhesion as calcium is essential 
to form cadherins [48, 49]. The contact to keratinocytes is important simulator to 
Figure 4. 
Pre- and postoperative local vitamin C injection in impacted canine traction [37].
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melanocytes to produce melanin, formation of dendrites and transfer the produced 
melanin to neighboring cells [48, 50]. Also, shortage of the intercellular copper 
limits the formation of tyrosine, tyrosinase enzyme, and peroxidase enzyme which 
in turn stops the melanin production [41].
Pain and itching were regarded as painful stimuli. Itching may transit to pain due 
to increased discharge frequency of nociceptors (intensity theory) [51] (Figure 5).
In 2016, Yussif et al. used the intraepidermic injection technique (oral meso-
therapy technique) in order to treat physiological hyperpigmentation. Vitamin 
C injection is a safe, minimally invasive nonsurgical depigmenting technique 
which also improves health of gingival tissues. They concluded that the direct 
effect of vitamin C could be due to the affinity of melanin to react with it, which 
in turn affects the cellular junctions (causing the immediate fainting) and forces 
such cells to spell out their contents of melanin leading to tissue darkening after 
a while. Further investigations and studies are recommended to detect its long-
term effect on the melanocytes and keratinocytes [29] (Figure 6).
During persistent gingival inflammation, Yussif et al. [45] have reported signifi-
cant enhancement of the gingival health by the usage of the intraepidermic vitamin 
C injection as an adjunctive approach for the conventional nonsurgical treatment 
modality.
During inflammation, it was found that the tissue antioxidant level (as vitamin 
C, vitamin E, etc.) decreases rapidly indicating the need of its supplementation. 
On the other hand, the free radical production increases at the site of inflamma-
tion [52, 53]. Extra doses of antioxidants especially vitamin C are essential. In 
localized inflammatory conditions, the administration of the needed higher doses 
via systemic route (higher than 500 mg) cannot be absorbed by the gastrointesti-
nal tract, which is easily excreted through urine. Moreover, in order to reach this 
dose at the site of inflammation, it needs administration of very high systemic 
doses that could be harmful to the patient. The local injection provides the needed 
dose efficiently [54] (Figure 7).
In 2014, [55] reported that the switch of the gingival tissue to the thick biotype is 
important to gingival and periodontal health as well as esthetic outcome. Ascorbic 
acid enhances the periodontal ligament maturation and renewal by induction of the 
collagen formation especially collagen III (young collagen) and keeps the balance 
between collagen I (mature collagen) and III for tissue maturation. It also modifies 
the rate of fibroblast proliferation [56]. In 2016, Yussif et al. reported the improve-
ment of the gingival biotype following the intraepidermic vitamin C injection 
ranging between 0.5 and 1 mm [29].
Figure 5. 
Pre- and postoperative histopathological photos of local vitamin C injection in treatment of gingival 
hyperpigmentation [29].
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4.4 Autogenous blood products
Platelet-rich plasma (PRP) is defined as a portion of the plasma element of 
autologous blood having a platelet concentration above baseline [56, 57]. It is 
considered as a growth factor agonist [58] with both mitogenic and chemotactic 
properties [56].
It was found that intralesional injection is a newly described method for applica-
tion of PRP and represents an effective therapeutic option when dealing with non-
healing wounds [59]. These findings open the door for using intralesional PRP in 
oral chronic ulcers. In 2015, El-Komy and his colleagues conducted a pilot study on 
seven patients suffering from resistant chronic oral pemphigus vulgaris (PV). All 
patients reported improvement in pain scores, ability to eat, and healing score [60].
In orthodontic therapy, significant improvement was reported following the 
introduction of local submucosal PRP injection in the pressure side. A single injec-
tion of PRP was enough during active orthodontic treatment (just 2 injections; pre 
and after 6 months). Acceleration of orthodontic tooth movement was reported 
1.7-fold when compared to the conventional traction technique [61] (Figure 8).
4.5 Hyaluronic acid
Black triangles or insufficient interdental papillae are considered a serious 
esthetic problem especially in patients with high lip line [62, 63].
Hyaluronic acid is an important component of the extracellular matrix, 
which has great role in maintaining the health of the oral tissues and healing and 
repair process. The mechanism of its action depends mainly on stimulating the 
cellular proliferation, migration, and vasculature and restoring the integrity of 
epidermal and dermal layer. It is also effective in stimulating collagen formation 
through enhancing the proliferation of fibroblasts. In dentistry, it is recently used 
Figure 6. 
Pre- and postoperative local vitamin C injection in physiologic gingival hyperpigmentation [29].
Figure 7. 
Pre- and postoperative local vitamin C injection in gingival inflammation [45].
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to accelerate the healing of oral ulcers [64], extraction socket [65], and gingival 
inflammation [66] either through injection or topical application. It was also used in 
reconstruction of the interdental papilla as a minimally invasive technique instead 
of the conventional surgical intervention [67, 68].
4.6 Parathyroid hormone injection
Parathyroid hormone is one of the essential hormones that affect the bone 
metabolism. It was found that its local injection provides acceleration of the orth-
odontic tooth movement 1.6 times faster than the normal movement range. A daily 
local injection of parathyroid hormone (PTH) was also used to induce local bone 
resorption by reducing the concentration of the gel medium using saline [69, 70].
4.7 Relaxin hormone injection
Relaxin is a specialized hormone which was detected in the periodontal liga-
ment providing proper remodeling of the soft tissue rather than the alveolar bone 
surrounding teeth. It provides the needed balance of the collagen content in the 
pressure and tension sites especially during application of forces as orthodontic 
treatment. It was found that the local injection of relaxin could provide an accel-
erated tooth movement by reducing the organization of the related periodontal 
ligaments and increasing the tooth mobility. A weekly injection of 50 μg of relaxin 
hormone was also found to accelerate tooth movement via soft tissue remodeling, 
rather than bone, through increasing the collagen at the tension side over its amount 
in the compression side. It also decreases the organization of the periodontal liga-
ments surrounding the tooth causing extra mobility [70–72].
4.8 Prostaglandin injection
Prostaglandin is one of the most important inflammatory mediators that is usu-
ally secreted during the inflammatory process. It is also considered as a paracrine 
hormone which affects mainly bone resorption level around the teeth by affecting 
the osteoclastic activity. It was found that its local application provides 1.6-fold of 
accelerated tooth movement than the normal range. Formerly, exogenous single or 
multiple prostaglandin injections were used [70, 73, 74].
4.9 Simvastatin
Simvastatin is a chemical agent that is usually used to reduce the serum cholesterol 
level. It was found that it has a positive, stimulatory effect to the bone by stimulation 
Figure 8. 
Submucosal injection of PRP during orthodontic treatment [61].
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of bone growth factors (e.g., BMP-2). On local injection, it was found that simvastatin 
could efficiently treat the infrabony defects and furcation defects and be used for guided 
bone regeneration. The injection visits could range from one to three times with 0.5–2 ml 
per visit. It is considered a successful nonsurgical treatment approach [75] (Figure 9).
4.10 Bone morphogenic proteins (BMPs)
In orthopedics, recombinant BMPs were commonly used during distraction of 
long bones in order to accelerate osteogenic potentials, increase bone volume (both 
width and height), improve bone density, and reduce relapse possibilities. BMP-2 
was commonly used with or without delivery systems as collagen sponge and 
chitosan hydrogel in sequential injections [75, 76] (Figure 10).
4.11 Combinations
Hyaluronidase is one of the proteolytic enzymes that are providing a physiologic 
limiting factor for intercellular cement substance, hyaluronic acid. It was used in 
the treatment of submucous fibrosis by promoting the lysis of accumulated fibrous 
tissues and relieving the stiffness of tissues by intralesional injection. It provides 
a rapid short-term improvement [29, 78]. In addition, corticosteroids could be 
combined with bisphosphonates in the treatment of central giant cell lesions with 
neither recurrence nor clinical side effects being detected [27].
Steroids are well-known immunosuppressive agents which offer a control of 
the inflammation. Up till now, different types of cortisone were used to undergo 
the needed outcome as triamcinolone and dexamethasone. Despite its potency, it 
was preferred because of its cost-effectiveness. Single-dose injection per week was 
needed till improvement is detected, which may extend to 4 months. Progression 
could be detected after two injections [29, 77].
Figure 9. 
Simvastatin injection [75].
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The usage of hyaluronidase and cortisone injection combination provides 
long-term improvement of the signs and symptoms associated with such diseases, 
bringing sensation, ulceration, and pain [29, 77].
5. Oral mesotherapy injection protocol
According to literature, up till now there is no definite protocol for dermal 
mesotherapy. In the oral cavity, it was more difficult to add specific rules due to the 
presence of multiple geometry, types, and dimensions of tissues as gingiva, buc-
cal mucosa, palate, tongue, etc.; we have tried to establish guidelines for general 
practitioners and beginners.
• Oral mesotherapy technique needs longer time for practice in order to achieve 
better results.
• Only minute quantities of injectable agent ranging between 0.05 and 
0.1 ml/point are permissible according to the range of the injected tissue 
expansion.
• In 1965, Woodard recommended that the pH of any injected material should 
range between 4.5 and 8.0. Local injections show lower rate of buffering 
capacity than intravenous and intramuscular route. During oral mesotherapy 
injection, higher pH is preferred.
Figure 10. 
Bone morphogenic protein injection [75].
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• The used needle has to be short, beveled. The needle’s gauge should range 
between 25 and 30.
• Numerous sites for administration of different injectable products are still accept-
able till now. The buccal mucosa, buccal vestibule, palate, labial gingival tissues, 
interdental papilla, and tongue are the most common sites for local injections.
• On the contrary to the skin, oral mucosa is always wet. Surface cleaning and 
dryness using dry gauze is recommended without the usage of surface disin-
fectant. Local anesthetic or analgesic agent (specific for intraoral usage) is also 
recommended accompanying the usage of specific agents as vitamin C due to 
its nature as a weak acid. In general, the usage of any injectable agent causes 
local inflammation and induces pain and itching.
• Preoperative treatment plan and patient preparation are the most important 
steps in the whole treatment procedure. Detailed patient’s medical history is an 
important issue. The target tissue should be free of infection and clean. Two visits 
for periodontal debridement are recommended; the first is preferred to be per-
formed 2 weeks prior to the procedure, while the other is usually performed prior 
to the injection visit especially if the injection will be more related to the teeth. 
The patient should be instructed to keep away from vitamin E and aspirin 1 week 
before the injection session. After the session, the patient must be instructed that 
discomfort or burning could occur for 20 minutes. Analgesics are not permitted.
6. Complications and criticism of mesotherapy
The main complications reported in this technique include ulceration, bleeding, 
infections, allergy, abscess, hyperpigmentation, and swelling related to the area to be 
injected [78, 79]. The main problems of mesotherapy are the lack of training of the 
practitioner, the difficulty to be evaluated except with biopsy, the inability to diag-
nose and treat a complication, and the lack of standardized dosage or formulation [1].
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